{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T22:59:56Z","timestamp":1791673196028,"version":"4.3.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["KR2047\/1-2, KR2047\/1-3, KR2047\/3-1"],"award-info":[{"award-number":["KR2047\/1-2, KR2047\/1-3, KR2047\/3-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"European Union Seventh Framework Programme","doi-asserted-by":"crossref","award":["(FP7\/2007-2013 n\u00b0263307"],"award-info":[{"award-number":["(FP7\/2007-2013 n\u00b0263307"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Wilhelm-Sander-Stiftung","award":["2016.124.1"],"award-info":[{"award-number":["2016.124.1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4055-9","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T08:00:21Z","timestamp":1517558421000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Elevated systemic levels of the matrix metalloproteinase inhibitor TIMP-1 correlate with clinical markers of cachexia in patients with chronic pancreatitis and pancreatic cancer"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0697-512X","authenticated-orcid":false,"given":"Olga","family":"Prokopchuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Gr\u00fcnwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Nitsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"J\u00e4ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleksii L.","family":"Prokopchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine C.","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Friess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc E.","family":"Martignoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim","family":"Kr\u00fcger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,2]]},"reference":[{"issue":"1","key":"4055_CR1","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/hep.27378","volume":"61","author":"B Seubert","year":"2015","unstructured":"Seubert B, Grunwald B, Kobuch J, Cui H, Schelter F, Schaten S, et al. Tissue inhibitor of metalloproteinases (TIMP)-1 creates a premetastatic niche in the liver through SDF-1\/CXCR4-dependent neutrophil recruitment in mice. Hepatology. 2015;61(1):238\u201348.","journal-title":"Hepatology"},{"key":"4055_CR2","first-page":"4292","volume":"6","author":"MN Holten-Andersen","year":"2000","unstructured":"Holten-Andersen MN, Stephens RW, Nielsen HJ, Murphy G, Christensen IJ, Stetler-Stevenson W, et al. High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer. Clin Cancer Res. 2000;6:4292\u20139.","journal-title":"Clin Cancer Res"},{"key":"4055_CR3","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1074\/mcp.M700305-MCP200","volume":"7","author":"SO Wurtz","year":"2008","unstructured":"Wurtz SO, Moller S, Mouridsen H, Hertel PB, Friis E, Brunner N. Plasma and serum levels of tissue inhibitor of metalloproteinases-1 are associated with prognosis in node-negative breast cancer: a prospective study. Mol Cell Proteomics. 2008;7:424\u201330.","journal-title":"Mol Cell Proteomics"},{"key":"4055_CR4","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2478\/ams-2013-0017","volume":"58","author":"M Kozlowski","year":"2013","unstructured":"Kozlowski M, Laudanski W, Mroczko B, Szmitkowski M, Milewski R, Lapuc G. Serum tissue inhibitor of metalloproteinase 1 (TIMP-1) and vascular endothelial growth factor a (VEGF-A) are associated with prognosis in esophageal cancer patients. Adv Med Sci. 2013;58:227\u201334.","journal-title":"Adv Med Sci"},{"key":"4055_CR5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12943-016-0515-5","volume":"15","author":"G Cheng","year":"2016","unstructured":"Cheng G, Fan X, Hao M, Wang J, Zhou X, Sun X. Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer. Mol Cancer. 2016;15:30.","journal-title":"Mol Cancer"},{"key":"4055_CR6","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13046-016-0427-7","volume":"35","author":"G Song","year":"2016","unstructured":"Song G, Xu S, Zhang H, Wang Y, Xiao C, Jiang T, et al. TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K\/AKT and MAPK pathway. J Exp Clin Cancer Res. 2016;35:148.","journal-title":"J Exp Clin Cancer Res"},{"key":"4055_CR7","first-page":"899","volume":"1","author":"ZS Zeng","year":"1995","unstructured":"Zeng ZS, Cohen AM, Zhang ZF, Stetler-Stevenson W, Guillem JG. Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases. Clin Cancer Res. 1995;1:899\u2013906.","journal-title":"Clin Cancer Res"},{"key":"4055_CR8","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1369\/0022155416656173","volume":"64","author":"W Alpizar-Alpizar","year":"2016","unstructured":"Alpizar-Alpizar W, Laerum OD, Christensen IJ, Ovrebo K, Skarstein A, Hoyer-Hansen G, et al. Tissue inhibitor of Metalloproteinase-1 is confined to tumor-associated Myofibroblasts and is increased with progression in gastric adenocarcinoma. J Histochem Cytochem. 2016;64:483\u201394.","journal-title":"J Histochem Cytochem"},{"key":"4055_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10120-008-0494-3","volume":"12","author":"T Yoshikawa","year":"2009","unstructured":"Yoshikawa T, Cho H, Tsuburaya A, Kobayashi O. Impact of plasma tissue inhibitor of metalloproteinase-1 on long-term survival in patients with gastric cancer. Gastric Cancer. 2009;12:31\u20136.","journal-title":"Gastric Cancer"},{"key":"4055_CR10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.prp.2015.11.014","volume":"212","author":"HJ An","year":"2016","unstructured":"An HJ, Lee YJ, Hong SA, Kim JO, Lee KY, Kim YK, et al. The prognostic role of tissue and serum MMP-1 and TIMP-1 expression in patients with non-small cell lung cancer. Pathol Res Pract. 2016;212:357\u201364.","journal-title":"Pathol Res Pract"},{"key":"4055_CR11","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.1038\/onc.2014.300","volume":"34","author":"H Cui","year":"2015","unstructured":"Cui H, Seubert B, Stahl E, Dietz H, Reuning U, Moreno-Leon L, et al. Tissue inhibitor of metalloproteinases-1 induces a pro-tumourigenic increase of miR-210 in lung adenocarcinoma cells and their exosomes. Oncogene. 2015;34:3640\u201350.","journal-title":"Oncogene"},{"key":"4055_CR12","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3389\/fphar.2012.00134","volume":"3","author":"H Cui","year":"2012","unstructured":"Cui H, Grosso S, Schelter F, Mari B, Kruger A. On the pro-metastatic stress response to cancer therapies: evidence for a positive co-operation between TIMP-1, HIF-1alpha, and miR-210. Front Pharmacol. 2012;3:134.","journal-title":"Front Pharmacol"},{"key":"4055_CR13","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s00109-015-1342-7","volume":"93","author":"A Kruger","year":"2015","unstructured":"Kruger A. Premetastatic niche formation in the liver: emerging mechanisms and mouse models. J Mol Med (Berl). 2015;93:1193\u2013201.","journal-title":"J Mol Med (Berl)"},{"key":"4055_CR14","doi-asserted-by":"crossref","unstructured":"Grunwald B, Harant V, Schaten S, Fruhschutz M, Spallek R, Hochst B, et al. Pancreatic pre-malignant lesions secrete TIMP1, which activates hepatic stellate cells via CD63 signaling to create a pre-metastatic niche in the liver. Gastroenterology. 2016;151(5):1011-24.","DOI":"10.1053\/j.gastro.2016.07.043"},{"key":"4055_CR15","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1097\/MPA.0b013e3181a488a0","volume":"38","author":"B Mroczko","year":"2009","unstructured":"Mroczko B, Lukaszewicz-Zajac M, Wereszczynska-Siemiatkowska U, Groblewska M, Gryko M, Kedra B, et al. Clinical significance of the measurements of serum matrix metalloproteinase-9 and its inhibitor (tissue inhibitor of metalloproteinase-1) in patients with pancreatic cancer: metalloproteinase-9 as an independent prognostic factor. Pancreas. 2009;38:613\u20138.","journal-title":"Pancreas"},{"key":"4055_CR16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/MPA.0b013e31825e354d","volume":"42","author":"KE Poruk","year":"2013","unstructured":"Poruk KE, Firpo MA, Scaife CL, Adler DG, Emerson LL, Boucher KM, et al. Serum osteopontin and tissue inhibitor of metalloproteinase 1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma. Pancreas. 2013;42:193\u20137.","journal-title":"Pancreas"},{"key":"4055_CR17","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/ijc.2910620409","volume":"62","author":"TM Gress","year":"1995","unstructured":"Gress TM, Muller-Pillasch F, Lerch MM, Friess H, Buchler M, Adler G. Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer. Int J Cancer. 1995;62:407\u201313.","journal-title":"Int J Cancer"},{"key":"4055_CR18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/(SICI)1096-9098(200002)73:2<95::AID-JSO7>3.0.CO;2-R","volume":"73","author":"YL Gong","year":"2000","unstructured":"Gong YL, Xu GM, Huang WD, Chen LB. Expression of matrix metalloproteinases and the tissue inhibitors of metalloproteinases and their local invasiveness and metastasis in Chinese human pancreatic cancer. J Surg Oncol. 2000;73:95\u20139.","journal-title":"J Surg Oncol"},{"key":"4055_CR19","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.3748\/wjg.v22.i10.2960","volume":"22","author":"H Zhang","year":"2016","unstructured":"Zhang H, Liu B, Xu XF, Jiang TT, Zhang XQ, Shi YL, et al. Pathophysiology of chronic pancreatitis induced by dibutyltin dichloride joint ethanol in mice. World J Gastroenterol. 2016;22:2960\u201370.","journal-title":"World J Gastroenterol"},{"key":"4055_CR20","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1021\/pr101148r","volume":"10","author":"S Pan","year":"2011","unstructured":"Pan S, Chen R, Crispin DA, May D, Stevens T, McIntosh MW, et al. Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling. J Proteome Res. 2011;10:2359\u201376.","journal-title":"J Proteome Res"},{"key":"4055_CR21","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1021\/pr201117w","volume":"11","author":"S Pan","year":"2012","unstructured":"Pan S, Chen R, Brand RE, Hawley S, Tamura Y, Gafken PR, et al. Multiplex targeted proteomic assay for biomarker detection in plasma: a pancreatic cancer biomarker case study. J Proteome Res. 2012;11:1937\u201348.","journal-title":"J Proteome Res"},{"key":"4055_CR22","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jprot.2014.10.001","volume":"113","author":"C Jenkinson","year":"2015","unstructured":"Jenkinson C, Elliott V, Menon U, Apostolidou S, Fourkala OE, Gentry-Maharaj A, et al. Evaluation in pre-diagnosis samples discounts ICAM-1 and TIMP-1 as biomarkers for earlier diagnosis of pancreatic cancer. J Proteome. 2015;113:400\u20132.","journal-title":"J Proteome"},{"key":"4055_CR23","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1080\/01635581.2013.804580","volume":"65","author":"J Bachmann","year":"2013","unstructured":"Bachmann J, Buchler MW, Friess H, Martignoni ME. Cachexia in patients with chronic pancreatitis and pancreatic cancer: impact on survival and outcome. Nutr Cancer. 2013;65:827\u201333.","journal-title":"Nutr Cancer"},{"key":"4055_CR24","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1093\/eurheartj\/eht302","volume":"35","author":"J Springer","year":"2014","unstructured":"Springer J, Tschirner A, Haghikia A, von Haehling S, Lal H, Grzesiak A, et al. Prevention of liver cancer cachexia-induced cardiac wasting and heart failure. Eur Heart J. 2014;35:932\u201341.","journal-title":"Eur Heart J"},{"key":"4055_CR25","doi-asserted-by":"crossref","unstructured":"Toneto AT, Ferreira Ramos LA, Salomao EM, Tomasin R, Aereas MA, Gomes-Marcondes MC. Nutritional leucine supplementation attenuates cardiac failure in tumour-bearing cachectic animals. J Cachexia Sarcopenia Muscle. 2016;7(5):577-86.","DOI":"10.1002\/jcsm.12100"},{"key":"4055_CR26","doi-asserted-by":"publisher","first-page":"H685","DOI":"10.1152\/ajpheart.00106.2015","volume":"309","author":"RD Devine","year":"2015","unstructured":"Devine RD, Bicer S, Reiser PJ, Velten M, Wold LE. Metalloproteinase expression is altered in cardiac and skeletal muscle in cancer cachexia. Am J Physiol Heart Circ Physiol. 2015;309:H685\u201391.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"4055_CR27","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12:489\u201395.","journal-title":"Lancet Oncol"},{"key":"4055_CR28","first-page":"363","volume":"21","author":"ME Martignoni","year":"2009","unstructured":"Martignoni ME, Dimitriu C, Bachmann J, Krakowski-Rosen H, Ketterer K, Kinscherf R, et al. Liver macrophages contribute to pancreatic cancer-related cachexia. Oncol Rep. 2009;21:363\u20139.","journal-title":"Oncol Rep"},{"key":"4055_CR29","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/1471-2407-12-265","volume":"12","author":"A Skorokhod","year":"2012","unstructured":"Skorokhod A, Bachmann J, Giese N, Martignoni ME, Krakowski-Roosen H. Real-imaging cDNA-AFLP transcript profiling of pancreatic cancer patients: Egr-1 as a potential key regulator of muscle cachexia. BMC Cancer. 2012;12:265.","journal-title":"BMC Cancer"},{"key":"4055_CR30","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12885-017-3116-9","volume":"17","author":"S Schwarz","year":"2017","unstructured":"Schwarz S, Prokopchuk O, Esefeld K, Groschel S, Bachmann J, Lorenzen S, et al. The clinical picture of cachexia: a mosaic of different parameters (experience of 503 patients). BMC Cancer. 2017;17:130.","journal-title":"BMC Cancer"},{"key":"4055_CR31","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s11605-008-0505-z","volume":"12","author":"J Bachmann","year":"2008","unstructured":"Bachmann J, Heiligensetzer M, Krakowski-Roosen H, Buchler MW, Friess H, Martignoni ME. Cachexia worsens prognosis in patients with resectable pancreatic cancer. J Gastrointest Surg. 2008;12:1193\u2013201.","journal-title":"J Gastrointest Surg"},{"key":"4055_CR32","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/1471-2407-9-255","volume":"9","author":"J Bachmann","year":"2009","unstructured":"Bachmann J, Ketterer K, Marsch C, Fechtner K, Krakowski-Roosen H, Buchler MW, et al. Pancreatic cancer related cachexia: influence on metabolism and correlation to weight loss and pulmonary function. BMC Cancer. 2009;9:255.","journal-title":"BMC Cancer"},{"key":"4055_CR33","doi-asserted-by":"crossref","unstructured":"Prokopchuk O, Steinacker J, Nitsche U, Otto S, Bachmann J, Schubert E, et al. IL-4 mRNA is downregulated in the liver of pancreatic cancer patients suffering from cachexia. Nutr Cancer. 2016;69 in press","DOI":"10.1080\/01635581.2017.1247885"},{"key":"4055_CR34","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1111\/j.1541-0420.2008.00995.x","volume":"64","author":"T Hothorn","year":"2008","unstructured":"Hothorn T, Zeileis A. Generalized maximally selected statistics. Biometrics. 2008;64:1263\u20139.","journal-title":"Biometrics"},{"issue":"Suppl 5","key":"4055_CR35","doi-asserted-by":"publisher","first-page":"v55","DOI":"10.1093\/annonc\/mdq165","volume":"21","author":"S Cascinu","year":"2010","unstructured":"Cascinu S, Falconi M, Valentini V, Jelic S, Group EGW. Pancreatic Cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(Suppl 5):v55\u20138.","journal-title":"Ann Oncol"},{"key":"4055_CR36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000354992","volume":"1","author":"W Hartwig","year":"2013","unstructured":"Hartwig W, Buchler MW. Pancreatic cancer: current options for diagnosis, staging and therapeutic management. Gastrointest Tumors. 2013;1:41\u201352.","journal-title":"Gastrointest Tumors"},{"key":"4055_CR37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s13539-011-0027-5","volume":"2","author":"JM Argiles","year":"2011","unstructured":"Argiles JM, Lopez-Soriano FJ, Toledo M, Betancourt A, Serpe R, Busquets S. The cachexia score (CASCO): a new tool for staging cachectic cancer patients. J Cachexia Sarcopenia Muscle. 2011;2:87\u201393.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"4055_CR38","first-page":"587","volume":"30","author":"MT Joergensen","year":"2010","unstructured":"Joergensen MT, Brunner N, De Muckadell OB. Comparison of circulating MMP-9, TIMP-1 and CA19-9 in the detection of pancreatic cancer. Anticancer Res. 2010;30:587\u201392.","journal-title":"Anticancer Res"},{"key":"4055_CR39","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ejso.2006.10.004","volume":"33","author":"KS Goonetilleke","year":"2007","unstructured":"Goonetilleke KS, Siriwardena AK. Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. Eur J Surg Oncol. 2007;33:266\u201370.","journal-title":"Eur J Surg Oncol"},{"key":"4055_CR40","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1053\/ejso.1999.0925","volume":"26","author":"DV Mann","year":"2000","unstructured":"Mann DV, Edwards R, Ho S, Lau WY, Glazer G. Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice. Eur J Surg Oncol. 2000;26:474\u20139.","journal-title":"Eur J Surg Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4055-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T01:47:09Z","timestamp":1570672029000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4055-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,2]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4055"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4055-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,2]]},"assertion":[{"value":"28 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The clinical and laboratory data could be used only after the consent of the patient to other scientific purposes. An Institutional Review Board \u201eEthikkommission der Technischen Universit\u00e4t M\u00fcnchen \u201capproved the study (Nr. 1946\/07). Written informed consent was obtained from the human subjects.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"128"}}